| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.9B | $5.4B | $4.6B | $4.0B | $3.5B | $0.6B | $0.7B | $0.6B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.5B | $0.5B | $0.4B | $0.3B | $0.3B | $0.0B | $0.1B | $0.0B |
| Net Income | $0.4B | $0.4B | $0.3B | $0.3B | $0.2B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $6.11 | $6.50 | $4.56 | $3.99 | $3.52 | $0.28 | $0.61 | $0.42 |
| EPS (Diluted) | $6.10 | $6.47 | $4.54 | $3.97 | $3.50 | $0.28 | $0.61 | $0.42 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.5B | $3.2B | $2.8B | $2.5B | $2.5B | $2.3B | $2.0B | $1.5B |
| Current Assets | $0.5B | $0.5B | $0.4B | $0.4B | $0.6B | $0.5B | $0.2B | $0.3B |
| Cash & Equivalents | $0.1B | $0.2B | $0.1B | $0.2B | $0.3B | $0.4B | $0.1B | $0.2B |
| Total Liabilities | $2.1B | $1.8B | $1.6B | $1.5B | $1.4B | $1.4B | $1.1B | $0.5B |
| Current Liabilities | $0.9B | $0.8B | $0.7B | $0.7B | $0.6B | $0.5B | $0.4B | $0.4B |
| Stockholders' Equity | $1.5B | $1.4B | $1.1B | $1.0B | $1.1B | $0.9B | $0.9B | $0.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.7B | $0.8B | $0.6B | $0.5B | $0.5B | $0.2B | $0.4B | $0.4B |
| Investing Cash Flow | $-0.5B | $-0.3B | $-0.4B | $-0.3B | $-0.2B | $-0.2B | $-0.2B | $-0.2B |
| Capital Expenditures | $0.4B | $0.4B | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B |
| Financing Cash Flow | $-0.4B | $-0.3B | $-0.3B | $-0.4B | $-0.3B | $0.2B | $-0.3B | $-0.1B |